OBS Medical to Attend the CBI and ACT’s 6th CardioVascular Risk Assessment Summit, January 30-31, 20
OBS Medical will be demonstrating BioQT, the future for Automated QT Analysis at the Cardiovascular Risk Assessment Summit. For more information come and meet us on the booth to discover the benefits BioQT can bring to your drug development trials.
For more information about OBS Medical, our products or services, please contact us.